| Tricyclic antidepressant pharmacology and therapeutic drug interactions updated PK Gillman British journal of pharmacology 151 (6), 737-748, 2007 | 503 | 2007 |
| Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity PK Gillman British journal of anaesthesia 95 (4), 434-441, 2005 | 411 | 2005 |
| The serotonin syndrome and its treatment PK Gillman Journal of Psychopharmacology 13 (1), 100-109, 1999 | 337 | 1999 |
| A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action PK Gillman Biological psychiatry 59 (11), 1046-1051, 2006 | 245 | 2006 |
| Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction RR Ramsay, C Dunford, PK Gillman British journal of pharmacology 152 (6), 946-951, 2007 | 217 | 2007 |
| Serotonin toxicity associated with the use of linezolid: a review of postmarketing data KR Lawrence, M Adra, PK Gillman Clinical infectious diseases 42 (11), 1578-1583, 2006 | 184 | 2006 |
| Serotonin syndrome: history and risk PK Gillman Fundamental & clinical pharmacology 12 (5), 482-491, 1998 | 177 | 1998 |
| CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity PK Gillman Journal of Psychopharmacology 25 (3), 429-436, 2011 | 116 | 2011 |
| Selective inhibitors of monoamine oxidase type B and the “cheese effect” JPM Finberg, K Gillman International review of neurobiology 100, 169-190, 2011 | 91 | 2011 |
| Neuroleptic malignant syndrome: mechanisms, interactions, and causality PK Gillman Movement disorders 25 (12), 1780-1790, 2010 | 87 | 2010 |
| Methylene blue implicated in potentially fatal serotonin toxicity PK Gillman Anaesthesia 61 (10), 1013-1014, 2006 | 81 | 2006 |
| Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review P Ken Gillman Headache: The Journal of Head and Face Pain 50 (2), 264-272, 2010 | 79 | 2010 |
| A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status PK Gillman Human Psychopharmacology: Clinical and Experimental 21 (2), 117-125, 2006 | 70 | 2006 |
| Human platelet phenolsulphotransferase: separate control of the two forms and activity range in depressive illness SMB Carter, V Glover, M Sandler, PK Gillman, PK Bridges Clinica Chimica Acta 117 (3), 333-344, 1981 | 69 | 1981 |
| Indolic substances in plasma, cerebrospinal fluid, and frontal cortex of human subjects infused with saline or tryptophan PK Gillman, JR Bartlett, PK Bridges, A Hunt, AJ Patel, BD Kantamaneni, ... Journal of Neurochemistry 37 (2), 410-417, 1981 | 69 | 1981 |
| Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium SC Stanford, BJ Stanford, PK Gillman Journal of Psychopharmacology 24 (10), 1433-1438, 2010 | 67 | 2010 |
| Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors PK Gillman Journal of clinical psychopharmacology 31 (1), 66-74, 2011 | 57 | 2011 |
| Serotonin syndrome PK Gillman, IM Whyte Adverse syndromes and psychiatric drugs, 37-49, 2004 | 42 | 2004 |
| Successful treatment of serotonin syndrome with chlorpromazine TR Norman Medical Journal of Australia 165 (6), 345-346, 1996 | 42 | 1996 |
| Substances related to 5‐hydroxytryptamine in plasma and in lumbar and ventricular fluids of psychiatric patients G Curzon, BD Kantamaneni, P Van Boxel, PK Gillman, JR Bartlett, ... Acta Psychiatrica Scandinavica 61 (S280), 3-20, 1980 | 42 | 1980 |
RONA R. RAMSAYReader in Biochemistry, University of St AndrewsVerified email at st-and.ac.uk
